| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▲ | 1.14▲ | 1.14▲ | 1.11▲ | 1.17▼ |
| MA10 | 1.14▲ | 1.14▲ | 1.12▲ | 1.13▲ | 1.20▼ |
| MA20 | 1.14▲ | 1.11▲ | 1.10▲ | 1.18▼ | 1.17▼ |
| MA50 | 1.12▲ | 1.11▲ | 1.13▲ | 1.22▼ | 1.66▼ |
| MA100 | 1.10▲ | 1.14▲ | 1.17▼ | 1.15▼ | 2.15▼ |
| MA200 | 1.13▲ | 1.19▼ | 1.22▼ | 1.54▼ | 16.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.006▲ | 0.009▲ | -0.009▼ | 0.027▲ |
| RSI | 65.234▲ | 67.823▲ | 61.917▲ | 46.173▼ | 44.765▼ |
| STOCH | 16.667▼ | 91.984▲ | 96.154▲ | 28.323 | 37.484 |
| WILL %R | -50.000 | -7.692▲ | -6.667▲ | -47.500 | -73.537 |
| CCI | -38.532 | 68.063 | 113.671▲ | -42.429 | -89.437 |
|
Friday, May 08, 2026 05:04 AM
May 7, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL ® gene silencing technology to ...
|
|
Sunday, February 22, 2026 04:00 PM
Phase 1b Trial Reported Approximately 65% Pathological Response in cSCC, Including Complete Responses at Maximum Dose, With No Serious Adverse Events Phio Pharmaceuticals Corp. (NASDAQ:PHIO) NEW YORK, ...
|
|
Sunday, February 22, 2026 04:00 PM
NEW YORK, NY, UNITED STATES, February 23, 2026 /EINPresswire.com/ — B2i Digital, Inc. today announced that Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has been ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/05/26 | 1.11 | 1.15 | 1.11 | 1.145 | 103,460 |
| 12/05/26 | 1.11 | 1.12 | 1.08 | 1.10 | 147,180 |
| 11/05/26 | 1.10 | 1.115 | 1.075 | 1.08 | 152,168 |
| 08/05/26 | 1.15 | 1.15 | 1.04 | 1.07 | 321,933 |
| 07/05/26 | 1.15 | 1.165 | 1.135 | 1.14 | 98,429 |
| 06/05/26 | 1.15 | 1.175 | 1.14 | 1.15 | 146,783 |
| 05/05/26 | 1.18 | 1.19 | 1.13 | 1.13 | 118,811 |
| 04/05/26 | 1.14 | 1.175 | 1.12 | 1.16 | 212,016 |
| 01/05/26 | 1.22 | 1.22 | 1.13 | 1.14 | 310,878 |
| 30/04/26 | 1.21 | 1.23 | 1.1905 | 1.22 | 80,433 |
|
|
||||
|
|
||||
|
|